tax_map_id
4,5
Codi
VHIR
Imatge
Image
Logotip VHIR
Image
Logotip VHIR

Innovation at the Vall d’Hebron Barcelona Hospital Campus

The last few years have seen a drastic change in how we understand and relate to medicine. Innovation is a strategic pillar for improving patient care at Vall d'Hebron Barcelona Hospital Campus, as it allows us to optimise processes and ensure high quality service.

Project description

At Vall d'Hebron Barcelona Hospital Campus, innovation is essential in ensuring that our services and patient care are of the highest quality and at the forefront of current medical trends. Our strength in healthcare, research and teaching means we constantly incorporate new knowledge, generating value not just for patients but for professionals and the wider organisation. This strategic emphasis drives us to overcome new challenges in social and health care, improving sustainability and efficiency in the health system.

This strategy has led to the following concrete results: the creation of 18 spin-offs and start-ups; the transfer of 74 patents; the implementation of 12 projects thanks to the 'Jo innovo' competition; and the participation of over 400 patients and professionals in co-creation processes. The figures demonstrate our commitment to applied innovation and its capacity to generate a real impact.

To drive the culture of innovation in the Campus, we promote initiatives such as the 'Jo innovo' Competition: a space where our professionals can present and develop innovative ideas that transform clinical practice and hospital organisation. The winners receive specialised training and the opportunity to discover innovative ecosystems in other European hospitals, through the European University Hospitals Alliance (EUHA).

To learn more about our innovation projects and initiatives, visit this section.

We support the promotion of projects that clearly support innovation in all areas.

Project partners

European University Hospitals Alliance (EUHA)

Vall d’Hebron is promoting the European University Hospital Alliance (EUHA) in collaboration with the most important hospitals in Europe, seeking to share innovative experiences and management models.

Project description

Vall d’Hebron is hosting the European University Hospital Alliance (EUHA), made up of Europe's largest university hospitals working collaboratively to improve present and future patient outcomes.

The European University Hospital Alliance was founded in 2017, with a view to sharing experience in the areas of health, research and education. Each of the members is a leading university hospital in its country, with a capacity of more than 1,000 beds. They are national reference centres and, together, supply 100% of the existing European Reference Networks (ERNs). Moreover, all members of the Alliance have centres of excellence in research and are affiliated to a university.

The overall objective of its members is to play an active role in shaping the future of healthcare in the European Union, sharing the best practices in order to benefit patients and maximising efforts to promote high quality research.

The objectives of the European University Hospital Alliance are:

  • To improve patient outcomes.
  • To improve the opportunities and experiences of members of the Alliance in all areas.
  • To strengthen relationships with key stakeholders, such as political leaders, the European Commission, pharmaceutical and medical technology companies and funding agencies.

The ten members of the European University Hospital Alliance are:

  • Allgemeines Krankenhaus der Stadt Wien - Vienna, Austria
  • Assistance Publique - Hôpitaux de Paris - Paris, France
  • Charité - Berlin, Germany
  • Erasmus Universität Medisch Centrum - Rotterdam, Netherlands
  • Hospital Universitari Vall d'Hebron - Barcelona, ​​Spain
  • Karolinska Universitetssjukhuset - Stockholm, Sweden
  • King's Health Partners - London, United Kingdom
  • Ospedale San Raffaele - Milan, Italy
  • UZ Leuven - Leuven, Belgium
  • Aarhus University Hospital - Aarhus, Denmark

Among all healthcare actors, university hospitals play an important role and are one of the main drivers and catalysts of innovation.

The Alliance sets out to improve communication between university hospitals; share good practices in the areas of patient care, innovation and other fields; and discuss issues in order to strengthen European healthcare systems. The Alliance also seeks to extend opportunities so that researchers, clinical professionals and other employees have the chance to acquire experience in other European university hospitals and develop professional networks.

Visit the Alliance website for more information: http://www.euhalliance.eu/

The European University Hospital Alliance has a view to sharing experience in the areas of health, research and education.

Catalan Network of Oncology

The Catalan Network of Oncology is the product of a strategic agreement between two public enterprises: the Catalan Health Institute (ICS) and the Catalan Oncology Institute (ICO). It coordinates cancer patient care around Catalonia and brings together specialised professionals in a joint care model that also aims to stimulate research. Its main objectives are: to guarantee integrated clinical care for oncological patients and to improve the ability to meet the challenges of precision medicine in cancer treatment.

Project description

The Catalan Network of Oncology treats 60% of cancer patients in Catalonia. It is made up of the Catalan Health Institute (ICS) and the Catalan Oncology Institute (ICO). On the one hand, the ICS runs two large hospitals offering cancer care: Vall d’Hebron University Hospital and Arnau Vilanova University Hospital. The ICO, meanwhile, can be found in Hospitalet, with centres in Girona, Badalona, Camp de Tarragona and Terres de l’Ebre.

The Network was born from the desire to become a world benchmark against cancer. A benchmark for innovation, research and care in Europe and the world. The Catalonia Health Plan 2016-2020 defines cancer as one of the region’s health priorities. It establishes strategic alliances and resource concentration to strengthen networks between leading tertiary centres and hospitals in the territory.

The Catalan Network of Oncology care model works on the following lines:

  • Frequent tertiary tumour programme: encompasses all care activity related to patients already diagnosed and the conventional therapeutic process.
  • Rare tumour programme: therapeutic plan applied to patients with rare tumours
  • Clinical research programme: includes all treatment within a clinical trial
  • Palliative care: care aimed at improving the quality of life of people with cancer
  • Associated Oncology Pharmacy Unit: improvement in the management capacity of the pharmacy, both in purchasing policies and in the management of service provision
  • Hospital tumour register and information systems: integration of information from different centres with the aim of facilitating a shared information unit

This model is reflected in that of other world leaders in cancer treatment. It uses precision medicine, which allows for personalised treatment to be provided; and knowledge management, which facilitates data recording, the assessment of results and the transfer of information between professionals. 

The Oncological Network of Catalonia covers 60% of cancer patients in Catalonia.

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.